PriceTargets.com logo

Anteris Technologies Global - AVR Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $16.00
  • Forecasted Upside: 104.08%
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$7.84 As of 07/31/2026 05:00 PM ET
▼ -0.4 (-4.85%)

This chart shows the closing price for AVR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Anteris Technologies Global Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVR

Analyst Price Target is $16.00
▲ +104.08% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Anteris Technologies Global in the last 3 months. The average price target is $16.00, with a high forecast of $18.00 and a low forecast of $15.00. The average price target represents a 104.08% upside from the last price of $7.84.

This chart shows the closing price for AVR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 5 investment analysts is to moderate buy stock in Anteris Technologies Global. This rating has held steady since March 2026, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/6/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/7/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/5/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/3/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
2/1/2026
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
5/2/2026
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
7/1/2026
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
7/31/2026

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/29/2026Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
5/15/2026BarclaysBoost TargetOverweight ➝ Overweight$17.00 ➝ $18.00
3/27/2026Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$15.00
3/12/2026Cantor FitzgeraldInitiated CoverageOverweight$15.00
3/11/2026Wells Fargo & CompanyInitiated CoverageOverweight$16.00
3/4/2026Cantor FitzgeraldUpgradeStrong-Buy
1/23/2026Lake Street CapitalReiterated RatingBuy ➝ Buy$15.00
12/29/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/22/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/15/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
12/1/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
11/25/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
11/19/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
10/30/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
10/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
1/8/2025Lake Street CapitalInitiated CoverageBuy$20.00
1/7/2025TD CowenInitiated CoverageBuy$15.00
1/7/2025Cantor FitzgeraldInitiated CoverageOverweight$9.00
1/7/2025BarclaysInitiated CoverageOverweight$22.00
(Data available from 8/1/2021 forward)

News Sentiment Rating

1.43 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
1/3/2026
  • 3 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2026
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2026
  • 3 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2026
  • 0 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2026
  • 4 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2026
  • 14 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2026

Current Sentiment

  • 14 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Anteris Technologies Global logo
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Read More

Today's Range

Now: $7.84
Low: $7.73
High: $8.39

50 Day Range

MA: $9.22
Low: $7.84
High: $10.57

52 Week Range

Now: $7.84
Low: $2.99
High: $11.06

Volume

1,034,877 shs

Average Volume

1,032,784 shs

Market Capitalization

$763.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.65

Frequently Asked Questions

What sell-side analysts currently cover shares of Anteris Technologies Global?

The following equities research analysts have issued research reports on Anteris Technologies Global in the last year: Barclays PLC, Cantor Fitzgerald, Lake Street Capital, Wall Street Zen, Weiss Ratings, and Wells Fargo & Company.
View the latest analyst ratings for AVR.

What is the current price target for Anteris Technologies Global?

0 Wall Street analysts have set twelve-month price targets for Anteris Technologies Global in the last year. Their average twelve-month price target is $16.00, suggesting a possible upside of 104.1%. Barclays PLC has the highest price target set, predicting AVR will reach $18.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $15.00 for Anteris Technologies Global in the next year.
View the latest price targets for AVR.

What is the current consensus analyst rating for Anteris Technologies Global?

Anteris Technologies Global currently has 1 sell rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for AVR.

What other companies compete with Anteris Technologies Global?

Other companies that are similar to Anteris Technologies Global include Establishment Labs, Warby Parker, TransMedics Group, LeMaitre Vascular and AxoGen. Learn More about companies similar to Anteris Technologies Global.

How do I contact Anteris Technologies Global's investor relations team?

Anteris Technologies Global's physical mailing address is 860 BLUE GENTIAN ROAD, SUITE 340, EAGAN, MN, 55121. The company's listed phone number is (651) 493-0606 and its investor relations email address is [email protected]. The official website for Anteris Technologies Global is anteristech.com. Learn More about contacing Anteris Technologies Global investor relations.